Calcium 관련 고혈압
C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'heartcited.com';
const params = 'ingredient\u003Dcalcium\u0026condition\u003Dhigh\u002Dblood\u002Dpressure';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
결론
Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
Key Study Findings
Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None
vs: Standard care or placebo
Outcome: Global cognition in stroke survivors
효과: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins)
0.009 (protein); 0.02 (B-vit)
대상 집단: Adult stroke survivors (20 trials + 14 observational)
Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily
vs: Placebo
Outcome: Preeclampsia risk reduction
효과: ~50% risk reduction
None
대상 집단: Pregnant women with low calcium intake
Review
Novel pharmacologic approaches in resistant hypertension.
Dose: Spironolactone, sacubitril/valsartan, SGLT2i
vs: None
Outcome: Blood pressure control in resistant HTN
효과: None
None
대상 집단: Patients with resistant hypertension
Review
Vegan Diet Health Benefits in Metabolic Syndrome.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: Adults with metabolic syndrome
cross-sectional observational study
n=260
Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
Dose: None
vs: Placebo
효과: None
None
Observational Study
n=40
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Dose: anti-digoxin antibodies (Fab)
vs: pre-treatment
Outcome: serum digoxin and clinical outcomes
효과: Fab bound digoxin; no improved clinical outcomes
None
대상 집단: Chronic digoxin toxicity patients
Key Statistics
13
연구
1500
참여자
↔
Mixed
C
등급
Referenced Papers
Hypertension research : …
2025
10 인용
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Meta-Analysis
Advances in nutrition …
2025
1 인용
Wiadomosci lekarskie (Warsaw, …
2024
Nutrients
2021
113 인용
Journal of renal …
2017
26 인용
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Observational
Clinical toxicology (Philadelphia, …
2016
25 인용
Trends in cardiovascular …
2016
19 인용
Nephro-urology monthly
2014
43 인용
Zhongguo Zhong yao …
2014
4 인용
British journal of …
2013
156 인용
Acta medica Indonesiana
2007
4 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- note:
- Prefer dietary sources; limit supplements to 500 mg/dose
- general:
- 1,000-1,200 mg/day from diet plus supplements
상한량: 2,000-2,500 mg/day (total from diet and supplements)
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| 500 mg daily | -- | Positive | -- |
| Spironolactone, sacubitril/valsartan, SGLT2i | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Neutral | 260 |
| anti-digoxin antibodies (Fab) | -- | Neutral | 40 |
| None | -- | Mixed | -- |
| None | -- | Neutral | 2991 |
권장 복용 시간: Divide doses (500 mg max per dose); carbonate with meals; citrate any time
Safety & Side Effects
보고된 부작용
- ⚠ Constipation (especially carbonate form)
- ⚠ Potential increased MI risk with high-dose supplements (controversial)
- ⚠ Kidney stones at excessive doses
- ⚠ Gas, bloating
알려진 상호작용
- ● Thyroid medications (separate by 4 hours)
- ● Bisphosphonates (separate by 30-60 minutes)
- ● Iron supplements (reduced absorption — separate by 2 hours)
- ● Certain antibiotics (reduced absorption)
- ● Vitamin K2 (may help direct supplemental calcium to bones, not arteries)
일일 최대 섭취 허용량: 2,000-2,500 mg/day (total from diet and supplements)
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Calcium help with 고혈압?
Based on 13 studies with 1,500 participants, there is limited but promising evidence that Calcium may support 고혈압 management. Our evidence grade is C (Some Evidence).
How much Calcium should I take for 고혈압?
Studies have used various dosages. A commonly studied range is Prefer dietary sources; limit supplements to 500 mg/dose. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Calcium?
Reported side effects may include Constipation (especially carbonate form), Potential increased MI risk with high-dose supplements (controversial), Kidney stones at excessive doses, Gas, bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Calcium and 고혈압?
We rate the evidence as Grade C (Some Evidence). This rating is based on 13 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.
Related Evidence
References
- [1] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
- [2] Sasan Amanat et al.. Adv Nutr. 2025. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis. doi:10.1016/j.advnut.2025.100440 PubMed
- [3] Jerzy Głuszek. Wiad Lek. 2024. Novel pharmacologic approaches in resistant hypertension. doi:10.36740/WLek/194090 PubMed
- [4] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
- [5] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
- [6] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
- [7] Alfonso Eirin et al.. Trends Cardiovasc Med. 2016. Emerging concepts for patients with treatment-resistant hypertension. doi:10.1016/j.tcm.2016.05.004 PubMed
- [8] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
- [9] Jian-hong Li et al.. Zhongguo Zhong Yao Za Zhi. 2014. [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. PubMed
- [10] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
- [11] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.